Clinical Trials in Arizona

Showing 5521-5540 of 16,770 trials

Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

NCT03539198

This study observes the clinical efficacy of combining proton SBRT with PD-1 blockade immunotherapy in both the locoregionally recurrent and metastatic settings.

Head and Neck Cancer

Mayo Clinic19 participantsStarted Jul 2018

Scottsdale, Arizona, United States • Rochester, Minnesota, United States

COMPLETEDPhase 231 miles

Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19

NCT04470544

To determine if the reduction in TMPRSS2 activity via direct inhibition with Camostat mesilate combined with standard of care (SOC) treatment will increase the proportion of patients alive and free from respiratory failure at Day 28 in SARS-CoV-2 as compared to SOC treatment with placebo.

Severe Acute Respiratory Syndrome

Alan Bryce100 participantsStarted Jul 2020

Scottsdale, Arizona, United States • Tucson, Arizona, United States

COMPLETEDPhase 1/242 miles

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

NCT02561455

The purpose of the study was to provide access to continued treatment for those who participated in other Astellas sponsored ASP2215 trials that completed the primary analysis and, had the potential to continue to derive clinical benefit from the treatment with ASP2215, and who did not meet any of the study discontinuation criteria in the present study.

Advanced Solid TumorsAcute Myeloid Leukemia

Astellas Pharma Global Development, Inc.9 participantsStarted May 2016

Phoenix, Arizona, United States • Baltimore, Maryland, United States • New York, New York, United States +4 more locations

Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

Find Trials by Condition in Arizona

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers

A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

LEV102 Topical Gel in Acquired Blepharoptosis

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Fever After Simultaneous Versus Sequential Vaccination in Young Children

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies